Bio Pharma Dive

FEBRUARY 16, 2021

The biotech is also suspending sales of its related treatment Zynteglo following a leukemia diagnosis in a clinical trial volunteer and a case of a cancer-like bone marrow disease in another.

Gene Therapy 315

Gene Therapy Gene Clinical Trials Clinical Trials 315

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 10, 2024

In order to avoid environmental hazards due to pharmaceutical products, the Department of Pharmaceuticals (DoP) is thinking of framing a ‘Disposal Policy’ for removing the unused and date-expired drugs from the sale premises and from the households.

Sales 188

Sales Drugs Production Clinical Trials 188

Bio Pharma Dive

MAY 5, 2022

The biotech reported positive results from a study meant to expand Vyvgart's use to another immune disorder, while sales from the drug's first quarter on the market exceeded expectations.

Sales 130

Sales Drugs Trials Marketing 130

Bio Pharma Dive

AUGUST 3, 2023

The company disclosed the study result alongside second quarter earnings showing Lumakras sales were flat versus the same period one year prior.

Sales 246

Sales Trials Drugs 246

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 14, 2022

The medical devices industry in the country has sought the Centre to define online and offline mode of sale, provide more clarity on the regulations that are binding the online sales and suggested inclusion of online medical devices players under the Uniform Code for Medical Devices Marketing Practices (UCMDMP).

Sales 182

Sales Regulation Marketing Drugs 182

Bio Pharma Dive

JULY 9, 2021

Zynteglo sales have been on hold since February, when a patient in a clinical trial of another, related Bluebird medicine developed leukemia.

Gene Therapy 271

Gene Therapy Gene Marketing Clinical Trials 271

Bio Pharma Dive

FEBRUARY 6, 2024

The company also reported trial results suggesting tirzepatide, the drug Lilly now sells as Mounjaro and Zepbound, could treat a common liver disease.

Sales 180

Sales Drugs Trials 180

pharmaphorum

OCTOBER 21, 2024

billion in the first half of the year.

Trials 109

Trials Sales Production 109

Pharmaceutical Technology

APRIL 28, 2023

Novo Nordisk’s leading drug Ozempic (semaglutide) is forecast to demonstrate a sales growth of 23% in 2023. Ozempic’s forecast 2023 sales of $12.5bn consolidate its position as the dominant market leader, with projected sales in 2023 54% greater than closest competitor Trulicity (dulaglutide) by Eli Lilly, which anticipates sales of $8bn.

Sales 130

Sales Insulin Marketing FDA Approval 130

pharmaphorum

NOVEMBER 19, 2021

So too are the sales figures. billion in vaccine sales this year. Disappointing late-stage trials of CureVac’s jab meant there was no competitive advantage, while Sanofi said the dominance of current vaccines made penetration in the market difficult. billion in covid vaccine sales in 2021. Katrina Megget reports.

Sales 137

Sales Vaccine Vaccination Marketing 137

Fierce Pharma

JUNE 17, 2024

Two back-to-back pivotal trial wins have rekindled hopes at GSK that once-failed multiple myeloma drug Blenrep could reach more than 3 billion pounds sterling in peak sales after all. |

Sales 108

Sales Marketing Trials Drugs 108

Pharmaceutical Technology

MARCH 28, 2023

5 adapted bivalent Covid-19 vaccine, the company has forecasted a slump in sales for 2023 as Covid-19 vaccine demand falls. In response to the lower vaccine sales forecasts, BioNTech shares opened at 3.9% In December 2022, BioNTech initiated a Phase I clinical trial of BNT163 – an HSV vaccine candidate.

Vaccine 276

Vaccine Vaccination Development Clinical Trials 276

Bio Pharma Dive

FEBRUARY 23, 2023

The biotech expects to earn at least $5 billion from sales of its COVID vaccine this year, which would be about one-third of what it made in 2022.

Trials 180

Trials Sales Vaccine Vaccination 180

XTalks

NOVEMBER 21, 2024

Participants were selected based on their prediabetic status, and the trial compared tirzepatide with a placebo. Participants in the trial also had comorbidities such as hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease or a combination of these conditions. Similarly, Zepbound’s sales in obesity totaled $1.26

Sales 105

Sales Insulin Drugs Trials 105

XTalks

APRIL 3, 2025

Eli Lilly shared new Phase II trial data showing that its experimental siRNA therapy, lepodisiran, leads to reductions in levels of lipoprotein(a) (Lp(a)) a genetically inherited risk factor for heart disease in adults with elevated levels of the marker. The 400 mg dose was the highest lepodisiran dose in the trial.

Trials 59

Trials Clinical Trials Clinical Trials Genetics 59

Bio Pharma Dive

JANUARY 29, 2024

An under-the-skin Opdivo shot produced similar results to an intravenous formulation in kidney cancer, giving Bristol Myers a chance at sustaining sales past a key patent expiration in 2028.

Sales 180

Sales Trials 180

Fierce Pharma

MAY 6, 2024

As BioNTech continues to endure a sharp decline in COVID-19 vaccine sales, the German mRNA specialist is looking ahead to the next leg of its commercial journey. With plans to have at least 10 potentially registrational trials underway by the end of 2024, BioNTech is plotting the first wave of its market debut in oncology from 2026 onward.

Sales 118

Sales Vaccine Vaccination Trials 118

Pharmaceutical Technology

SEPTEMBER 15, 2022

As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. Pfizer reaped $36.8bn from Comirnaty, the highest revenue generated from Covid-19 vaccine sales worldwide. YoY revenue growth.

Vaccine 272

Vaccine Vaccination Sales Generic Drugs 272

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2024

The Drugs Technical Advisory Board (DTAB) of the Union health ministry has once again recommended prohibiting the manufacture, sale and distribution of pain relief drug combination S(+) etodolac+paracetamol, after considering a sub-committee report.

Manufacturing 246

Manufacturing Sales Drugs Clinical Trials 246

Velocity Clinical Research

MARCH 23, 2025

Clinical trials have been steadily leaving the UK for years. of patients recruited to global trials were from the UK. Thats not to say we dont still have some clout (the UK ranks fourth globally for Phase II trials ), but the trending outflow needs to be addressed. In 2021, just 2.2% So, delays cost money, and the NHS is slow.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

pharmaphorum

FEBRUARY 27, 2024

Europe's commercial leaders are gearing up for a faster trial-to-treatment pathway, leveraging CRM technology to empower HCPs and sales teams.

Trials 115

Trials Sales 115

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 12, 2025

But it can be hard to work out the difference between all the types on sale. (Laura Leyshon/Getty Images) If you head to the shops to buy bread, you’ll face a variety of different options. For instance, you might have a vague idea that wholemeal or wholegrain bread is healthy. But what’s the difference? Here’s […]

Sales 210

Sales Clinical Trials Clinical Trials Trials 210

XTalks

JANUARY 17, 2025

Related: Intra-Cellulars Schizophrenia Drug Caplyta Shows Promising Trial Results for Relapse Prevention Offered as a simplified once-daily dosing regimen, patients can begin treatment at the effective dose without the need for gradual escalation. Caplytas safety profile is consistent with existing clinical data.

Drugs 105

Drugs Trials Sales Life Science 105

XTalks

FEBRUARY 24, 2025

Carlsbad, California-based Ionis Pharmaceuticals announced it will be sharing promising new trial data for its RNA-targeted prophylactic treatment donidalorsen for hereditary angioedema (HAE) at the 2025 American Academy of Allergy, Asthma & Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress in San Diego, California.

Trials 59

Trials RNA Allergies Drugs 59

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 10, 2022

A new anti-hangover supplement has just gone on sale in the UK. It is marketed by Swedish firm Myrkl as “the pre-drinking pill that works” The pill is said to break down up to 70 percent of alcohol after 60 minutes. This means that if someone drinks 50 ml of 40 percent spirits, which contains […].

Containment 246

Containment Sales Marketing Clinical Trials 246

Pharmaceutical Technology

SEPTEMBER 6, 2024

GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.

Sales 130

Sales Trials 130

Pharmaceutical Technology

JUNE 7, 2023

The recent rallying of Lilly’s market value has come as the result of two major announcements: its blockbuster type 2 diabetes (T2D) drug Mounjaro (tirzepatide) successfully completed its second final-stage trial for obesity, and its experimental treatment for Alzheimer’s disease completed its Phase III trial.

Marketing 246

Marketing Sales Trials Drugs 246

XTalks

DECEMBER 18, 2024

Related: Arrowhead Pharmas New Rare Disease Campaign for FCS Highlights Importance of Lowering Triglycerides The FDAs approval of Crenessity was based on two randomized, double-blind, placebo-controlled trials in 182 adults and 103 children with classic CAH. Crenessity marks the third approved drug for Neurocrine. billion in revenue by 2024.

Genetics 116

Genetics Hormones Trials Drugs 116

pharmaphorum

FEBRUARY 21, 2022

It’s a key moment for the two companies, as expansion into HER2-low breast cancer has been held up as a key requirement for Enhertu (trastuzumab deruxtecan) if it is to achieve its multibillion-dollar sales expectations. billion to Daiichi Sankyo if all the ADC’s development and sales objectives are achieved.

Trials 132

Trials Sales Hormones Drugs 132

Pharmaceutical Technology

OCTOBER 30, 2022

Undefined’s ionic propulsion drone has completed an outside flying test and plans to go on sale in 2024. The post Undefined Trials eVTOL Ion Propulsion Drone appeared first on Pharmaceutical Technology. Outlook: The industry for drone logistics and shipping is expanding rapidly. This article was originally published in Verdict.co.uk.

Trials 130

Trials Sales Research 130

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 23, 2023

With the chemists and druggists across the country opposing the sale of drugs through online, the Central government is taking a stand that the sale of medicines should be strictly under the provisions of the existing regulations and the State Licensing Authorities (SLAs) are legally empowered to act against violation of the legal provisions.

Pharmacy 188

Pharmacy Sales Licensing Licensing 188

XTalks

JANUARY 3, 2025

In this blog, we delve into the recent sales data to highlight the top three best-selling eye drugs in 2023. Lets take a closer look at Eylea, Vabysmo and Lucentis the ophthalmology drugs that led the pack in recent sales figures. Related: Top 30 Drugs to Watch in 2024: Insights from 2023 Sales Data 1. billion, down from $1.50

Sales 85

Sales FDA Approval Drugs Medicine 85

XTalks

JANUARY 6, 2025

In clinical trials, Alyftrek demonstrated non-inferiority to Trikafta, showing similar improvements in lung function and a reduction in sweat chloride levels. With the largest Phase III CF clinical trial program in history, involving over 1,000 participants across 20 countries, the results were promising, paving the way for broader use.

Gene Therapy 105

Gene Therapy Protein Genetic Disease Gene 105

Pharmaceutical Technology

DECEMBER 4, 2023

in tiered royalties on worldwide sales of Qtorin rapamycin. Palvella will receive $5m as an upfront payment, with Ligand getting 8%-9.8%

Sales 130

Sales Trials 130

World of DTC Marketing

OCTOBER 21, 2021

More than $170 million of this spending was for products voluntarily withdrawn by their manufacturers after clinical trials showed that they did not improve overall survival in people with various types of cancer. Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5

Clinical Trials 234

Clinical Trials Clinical Trials FDA Approval Trials 234

Bio Pharma Dive

MARCH 12, 2024

The setback shuts out Acadia’s top medicine from a large sales opportunity and heightens the biotech’s dependence on a pipeline filled with risky drug prospects.

Drugs 126

Drugs Sales Trials Medicine 126

Pharmaceutical Technology

MAY 19, 2023

AbbVie anticipates Rinvoq sales to exceed $7.5bn in 2025 and for the peak revenues from both drugs to exceed Humira’s peak sales by 2027. The FDA has recommended that patients start with 45mg Rinvoq once daily for 12 weeks, with a maintenance dosage of 15mg following the 12-week period.

FDA Approval 264

FDA Approval Dermatology Sales Clinical Trials 264